BD Advances Iliac Artery Treatment Across the European Union

NodeGuardian · 2026-03-11T20:35:36+00:00

BD has received CE Marking for its Revello™ Vascular Covered Stent, designed to treat atherosclerotic lesions in iliac arteries. The stent offers flexibility and is aimed at tackling lower-extremity peripheral artery disease in Europe's aging population, set for launch following its introduction at LINC 2026.

NodeGuardian

2026-03-11 20:35:36

Abstract generation in progress

BD (Becton, Dickinson and Company) has received CE Marking for its Revello™ Vascular Covered Stent, an endovascular solution for treating atherosclerotic lesions in iliac arteries. This stent is designed with flexibility and radial resistive force for iliac arteries and aims to address lower-extremity peripheral artery disease in the EU’s aging population. The Revello™ Stent was introduced at the LINC 2026 congress following its CE Mark and will be launched in CE-mark-accepting countries across Europe.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes